Mirogabalin Besylate

Mirogabalin Besylate API (CAS No: 1138245-21-2) is a pharmaceutical compound used in the development of formulations intended for neuropathic pain management. Classified under the gabapentinoid class, it is utilized in modern therapeutic segments focusing on nerve-related pain conditions and central nervous system applications.

This material is primarily incorporated in the formulation of oral solid dosage forms, including tablets and capsules, where consistent performance and formulation compatibility are essential. Its pharmacological profile and increasing demand in regulated and semi-regulated markets make it a valuable component in specialized pharmaceutical manufacturing.

The product is supplied in compliance with internationally accepted pharmacopeial standards such as USP, BP, and EP (as applicable). It is handled under controlled conditions to maintain high purity, stability, and batch-to-batch consistency. Each shipment is supported with standard documentation aligned with global regulatory expectations, including COA, MSDS, and other required certifications.

Kelar Pharmachem India serves as a reliable global sourcing partner for Mirogabalin Besylate API, ensuring consistent supply through trusted and validated networks. The product is packed in export-compliant packaging to preserve quality during international transit, with flexible packaging options available as per client requirements.

The company caters to pharmaceutical manufacturers and distributors across key international markets, including Asia, Africa, the Middle East, and Latin America. With a commitment to long-term business relationships, Kelar Pharmachem India delivers dependable supply, competitive positioning, and professional export support tailored to global industry standards.